Ticker League

Total Debt for Vertex Pharmaceuticals (VRTX)

As of · Reported

Metric

Latest period

$1.99B

YoY change

+121.9%

5Y CAGR

+33.0%

Peak year (2025)

$3.88B

Total Debt history chart for Vertex Pharmaceuticals (VRTX) from 1990 to 2025

Latest: $3.88B

Total Debt growth chart for Vertex Pharmaceuticals (VRTX) from 1990 to 2025

Latest: +121.9%

Total Debt history table for Vertex Pharmaceuticals (VRTX) from 1990 to 2025

  • 2025$3.88B+121.9%
  • 2024$1.75B+116.4%
  • 2023$808.40M-10.1%
  • 2022$899.70M-7.0%
  • 2021$967.40M+3.8%
  • 2020$931.90M+40.8%
  • 2019$661.66M+12.8%
  • 2018$586.82M-3.2%
  • 2017$606.43M-27.9%
  • 2016$840.76M+1.8%
  • 2015$826.24M+0.2%
  • 2014$824.95M+62.8%
  • 2013$506.58M-27.3%
  • 2012$696.91M+52.8%
  • 2011$455.95M-15.1%
  • 2010$536.99M+188.8%
  • 2009$185.91M-35.3%
  • 2008$287.50M+1337.7%
  • 2007$20.00M-83.8%
  • 2006$123.75M-31.3%
  • 2005$180.10M-46.2%
  • 2004$335.00M-7.9%
  • 2003$363.85M+10.9%
  • 2002$328.14M+0.2%
  • 2001$327.61M-9.6%
  • 2000$362.34M+5033.0%
  • 1999$7.06M-28.0%
  • 1998$9.80M+16.7%
  • 1997$8.40M-1.2%
  • 1996$8.50M+21.4%
  • 1995$7.00M+9.4%
  • 1994$6.40M+6.7%
  • 1993$6.00M+17.6%
  • 1992$5.10M+54.5%
  • 1991$3.30M+3.1%
  • 1990$3.20M—

Total Debt values are taken from Vertex Pharmaceuticals's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Total Debt at Vertex Pharmaceuticals (VRTX)

According to Vertex Pharmaceuticals's latest reported financial statements, the company's latest reported total debt is $1.99B. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — compare with cash on hand for net leverage, and total liabilities for the broader obligations picture.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Vertex Pharmaceuticals (VRTX) most recent annual total debt stands at $3.88B (2025) – surged 121.9% year-over-year.

Looking at the 2020–2025 (5 years) stretch, Vertex Pharmaceuticals total debt compounded at +33.0% per year, with mixed annual results across the window.

The highest annual total debt of $3.88B was reported in 2025. The lowest in the available history was $3.20M in 1990.

Vertex Pharmaceuticals Total Debt by Year

Vertex Pharmaceuticals Total Debt 2025: $3.88B

In 2025, Vertex Pharmaceuticals reported total debt of $3.88B, surged 121.9% from 2024. This figure represents the highest annual value in the available history.

Vertex Pharmaceuticals Total Debt 2024: $1.75B

Vertex Pharmaceuticals total debt in 2024 was $1.75B, surged 116.4% from 2023.

Vertex Pharmaceuticals Total Debt 2023: $808.40M

2023's total debt for Vertex Pharmaceuticals came in at $808.40M, declined 10.1% below 2022.

Vertex Pharmaceuticals Total Debt 2022: $899.70M

Vertex Pharmaceuticals posted total debt of $899.70M in 2022, declined 7.0% below 2021.

Vertex Pharmaceuticals Total Debt 2021: $967.40M

Vertex Pharmaceuticals total debt in 2021 was $967.40M.

See more financial history for Vertex Pharmaceuticals (VRTX).

Sector peers by Total Debt

Healthcare peers of Vertex Pharmaceuticals (VRTX), ranked by their latest total debt

Frequently asked questions

Vertex Pharmaceuticals (VRTX) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation